Related Experiment Videos
Immunoglobulin (Gm) allotype frequencies in patients with giant bell arteritis and polymyalgia rheumatica
Insights
The immunoglobulin allotypic marker Glm(2) was significantly increased in patients with giant cell arteritis (GCA), suggesting a potential genetic link. This finding was less pronounced in polymyalgia rheumatica (PMR) patients.
Area of Science:
- Immunogenetics
- Rheumatology
Background:
- Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) are inflammatory conditions with unknown etiology.
- Genetic factors are suspected to play a role in the pathogenesis of PMR and GCA.
Purpose of the Study:
- To investigate the association between immunoglobulin (Gm) allotypes and the prevalence of PMR and GCA.
- To explore potential genetic markers for these rheumatologic diseases.
Main Methods:
- Immunoglobulin (Gm) allotyping was performed on 55 Caucasoid patients diagnosed with PMR or GCA.
- Patient data included previous HLA-A, B, C, and DR locus allotyping for 44 individuals.
Main Results:
- A significant increase in the Glm(2) immunoglobulin allotypic marker was observed in the GCA patient group compared to controls (50.00% vs. 18.75%, P < 0.01).
- A similar, though not statistically significant, increase in Glm(2) was noted in the PMR group (27.24% vs. 18.75%).
- The rise in Glm(2) in GCA patients was attributed to the Glm(1,2,3,):G3m(5,10,21)phenotype.
Conclusions:
- The Glm(2) allotype may be a genetic risk factor associated with giant cell arteritis.
- Further research is warranted to elucidate the role of specific immunoglobulin allotypes in the immunopathogenesis of PMR and GCA.
Abstract:
Fifty-five Caucasoid patients with polymyalgia rheumatica (PMR) or giant cell arteritis (GCA) were immunoglobulin (Gm) allotyped for this study. Forty-four of these patients had been previously HLA-A,B,C and DR locus allotyped. The incidence of the immunoglobulin allotypic marker Glm(2) was significantly increased in the GCA group (50.00% v. controls 18.75%, P equal less than 0.01). There was a similar but insignificant rise of this Gm marker in the PMR group (27.24% v. 18.75%, NS). The increase in Glm(2) in the GCA group was not accompanied by a corresponding rise in the number of people homozygous for Glm(2), i.e., all the increase could be attributed to patients with the Glm(1,2,3,):G3m(5,10,21)phenotype.